Sponsor Pipeline

I-Mab Biopharma US Limited Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07432295 Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive… Solid Tumor Recruiting
Phase 1
NCT04900818 Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors Solid Tumor Recruiting
Disease Areas
Gastric Cancer (2) Pancreatic Cancer (1) Cholangiocarcinoma (1)
Get alerts when I-Mab Biopharma US Limited's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free